What We Offer Partners

• Target feasibility assessment and druggability scoring
• AI-guided LNA mixmer library design and optimization
• In vitro validation with dose-response characterization
• In vivo PK/PD and tissue distribution in rodent models
• Optimized lead candidates with preliminary CMC assessment
• Target-to-lead timelines measured in months, not years